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Abstract
Background: Anti-GAD-related cerebellar ataxia has rarely been described as an acute cause of autoimmune ataxia.
Phenomenology Shown: A young female who acutely developed anti-GAD-associated ataxia with magnetic resonance imaging (MRI) showing cerebellar
edema and follow-up MRI 6 months later showing cerebellar atrophy.
Educational Value: Recognizing that anti-GAD-associated cerebellar ataxia can present in a young adult as an acute and severe cause of ataxia, with cerebellar
changes evident on MRI.
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A 22-year-old previously healthy Caucasian female presented with
myalgia, fever, headache and cough. She tested positive for influenza
A and was started on oseltamivir. Two days later, she showed
mild confusion and dysarthria, followed the next day by extremities
and head tremor and ataxic gait. She went to an outside hospital
where cerebrospinal fluid (CSF) results were the following: red blood
cells, 9,700 per mm3; white blood cells 102 per mm3; segmented
neutrophils, 80%; lymphocyte, 14%; protein, 98.5 mg/dL; glucose
61 mg/dL. Human immunodeficiency virus and Lyme antibodies
were negative. Brain magnetic resonance imaging (MRI) on admission
showed cerebellar edema and hydrocephalus (Figure 1). She was
treated empirically with antibiotics, acyclovir, oseltamivir, and
dexamethasone 10 mg every 6 hours for 1 week. The following CSF
tests were negative: bacterial and fungal cultures, venereal disease
research laboratory (VDRL), Herpes polymerase chain reaction,
West Nile antibodies, coccidioidomycosis antibodies, Cryptococcus
antigen, and N-methyl-D-aspartate (NMDA) antibodies and cytol-
ogy. Her speech remained severely dysarthric. She showed truncal
ataxia, kinetic tremor in her four extremities, with dysdiadocho-
kinesia and dysmetria. The lumbar puncture was not repeated
because she developed a CSF leak. Chest, abdomen, and pelvis con-
trast tomography and pelvic ultrasound did not show evidence of
malignancy.
Thyroid peroxidase antibodies were positive with a normal
thyroid function. At day 19 from symptom onset she received 1 g of
methylprednisolone daily for 5 days with minimal improvement of
symptoms. After discharge, the send-out laboratory results came
back for the central nervous system autoimmune panel showing
elevated serum anti-glutamic acid decarboxylase (GAD) 65 titers:
0.07 nmol/L (normal ,0.02 nmol/L). She was lost to follow-up for
a few weeks. When she attended our clinic, her cognitive problems
had completely resolved but her cerebellar symptoms remained
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similar. She was started on monthly intravenous immunoglobulin
therapy (0.4 g/kg/day for 5 days, monthly); she has received it for
several months with partial improvement of the ataxia. Brain MRI
6 months from disease onset showed significant cerebellar atrophy
(Figure 2).
Anti-GAD-associated cerebellar ataxia affects mostly women in
about 80–90% of cases, occurring mainly in their sixth decade of
life. Most patients develop a chronic presentation, whereas around
one-third of cases present with subacute symptoms;1 very rarely has it
been reported as an acute condition.2
Imaging studies of anti-GAD 65-related cerebellar syndrome
were reported to be either normal or to indicate cerebellar atrophy.3
This case, with rapid onset of cerebellar symptoms and imaging
evidence of active changes in the cerebellum, implies that it can
present as an acute cerebellar inflammatory process than can affect
young patients.
Figure 1. Brain MRI Demonstrating Cerebellar Inflammation. (A) Brain magnetic resonance imaging (MRI), axial view, fluid-attenuated inversion
recovery sequence showing high signal intensity in the cerebellar hemisphere with dilatation of temporal horns of the lateral ventricles due to hydrocephalus.
(B) MRI brain, axial view, post-contrast T1-weighted sequence demonstrating prominence of perforating vessels in the cerebellar hemispheres but no apparent
parenchymal enhancement. A and B scans were obtained at the initial presentation. (C) Brain MRI, axial view, FLAIR sequence. This scan was done 20 days from
disease onset. It shows subtle increased T2 signal within the bilateral cerebellar hemispheres, improved, in comparison with previous studies. It also shows
improvement of the hydrocephalus.
Figure 2. Brain MRI Demonstrating Cerebellar Atrophy. (A) Brain magnetic resonance imaging (MRI), sagittal view, T1-weighted image at the level of
midline cerebellum, this image was obtained at the initial presentation. (B) Brain MRI, sagittal view, T1-weighted image. This is a follow-up MRI at 6 months after
disease onset showing significant cerebellar atrophy.
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